Heartburn
📧 Sign up to get email alerts when something new happens for Heartburn.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Domperidone in Treating Patients With Gastrointestinal Disorders [Phase 3]
A Phase 3 clinical trial evaluating domperidone for several gastrointestinal disorders is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Clinical Trial of PepZinGI® for Acute Heartburn Relief and Sleep Outcomes [NA]
This clinical trial is currently recruiting to evaluate PepZinGI for acute heartburn relief and sleep outcomes. Sponsored by NutriScience In…
-
FDA approval · 2025-09-30FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete (famotidine with calcium carbonate and magnesium hydroxide) chewable tablets to …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms. [NA]
A completed clinical trial evaluated the LEFT Smartwatch App as sleep positional therapy for nocturnal gastroesophageal reflux symptoms.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Smartphone App-assisted PPI [NA]
Completed clinical trial evaluating smartphone app-assisted use of proton pump inhibitors for heartburn and dyspepsia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2025-02-11FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
The FDA approved a supplemental application for Pepcid Complete, a chewable tablet combining famotidine with calcium carbonate and magnesium…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Remote Guided Caffeine Reduction [NA]
A Johns Hopkins-sponsored trial evaluating remote-guided caffeine reduction in individuals with caffeine dependence and anxiety has complete…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]
This completed study evaluated whether Antareit 800 mg chewable tablets are pharmacodynamically equivalent to Riopan 800 mg chewable tablets…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers [NA]
Clinical trial compares pharmacodynamics and pharmacodynamic equivalence of Antareit 800 mg/10 ml oral suspension and Riopan 800 mg chewable…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) [Phase 3]
Phase 3 trial evaluating vonoprazan versus placebo for relief of heartburn in non-erosive gastroesophageal reflux disease has completed with…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease [Phase 2]
Phase 2 trial comparing vonoprazan to placebo in symptomatic non-erosive gastroesophageal reflux disease has completed with results posted.
-
FDA approval · 2022-11-01FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
FDA approved a supplemental application for ZEGERID OTC by Riley Consumer Care LLC. The product contains omeprazole sodium bicarbonate.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Symptom Control Satisfaction With Proton Pump Inhibitor Regimen [Phase 4]
Phase 4 clinical trial update on symptom control satisfaction with a proton pump inhibitor regimen for heartburn.
-
FDA approval · 2022-01-28FDA Approved: CURIST ACID RELIEF — Original Application (Little Pharma, Inc.)
The FDA approved CURIST ACID RELIEF, a 20 mg famotidine tablet from Little Pharma, Inc., under an original ANDA.
-
FDA approval · 2020-01-30FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dexlansoprazole for heartburn relief in Chinese patients.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing Gastroduodenoscopy [Phase 4]
Phase 4 trial evaluating an articaine lozenge to improve procedural compliance during gastroduodenoscopy in adults with dyspepsia or hematem…
-
FDA approval · 2019-01-15FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole and sodium bicarbonate) submitted by Riley Consumer Care LLC.
-
FDA approval · 2018-12-21FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete, a chewable tablet that combines famotidine with calcium carbonate and magnesium…
-
FDA approval · 2017-10-30FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved a supplemental application for ZEGERID OTC (omeprazole with sodium bicarbonate) under Riley Consumer Care LLC, supporting i…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment [Phase 4]
Pfizer-sponsored Phase 4 pilot trial completed to explore the relationship between acid control and heartburn symptoms after proton pump inh…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Response to Supplement and Placebo in GERD [NA]
A completed clinical trial conducted at Beth Israel Deaconess Medical Center compared a supplement to placebo for GERD symptoms, including h…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Efficacy and Safety of Itopride vs Placebo in Heartburn [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Itopride versus placebo in heartburn has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn [Phase 1]
A Phase 1 clinical trial investigated whether E-cadherin levels in tissue or blood could help identify and monitor patients with heartburn a…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144) [Phase 1]
Phase 1 bioequivalence study comparing famotidine chewable tablets to film-coated tablets has completed, with results posted.